Accelerate drug development           Proteomics technology           

 Pharmacokinetics and Clinical Trials

By studying proteins in more detail new insights into the precise nature, diagnostic value, and quality of many biomarkers can be obtained. Diagnostic assays that target IBI-identified protein variants can improve accuracy and reliability. In some cases PTM's may indicate a predilection for disease and can be used to stratify patients in clinical trials for improved outcomes. Patient safety can be enhanced by monitoring a broad range of indicators in parallel. Monitoring structural changes of protein therapeutics as they occur in vivo provides a more complete pharmacokinetic profile and avoids costly complications.

Explore this section
Biomarker discovery
Population Proteomics
Research Programs

Related information
Client Services
Proteomics technology
Request Information

Home | Sitemap | Directions | Literature